The number of students admitted to doctoral programs this fall fell 15% from a year earlier across more than 50 of the nation’s top research universities, The New York Times reported July 6. This decline could shrink the scientific talent pipeline that supports hospitals and the broader healthcare industry.
The figure comes from 55 members of the Association of American Universities, an invitation-only group of 69 of the country’s most prestigious research institutions. AAU member schools confer half of the nation’s research doctorates.
The story does not stop at the campus gates. The same funding pressures are thinning the ranks of physician-scientists and PhD-prepared nurse scientists — roles hospitals increasingly rely on to run clinical trials, drive evidence-based practice and lead quality improvement. Here are six things to know:
1. The declines are stacking on top of one other.
This fall’s 15% drop follows an 11% decline in new PhD enrollment last year among the 42 schools that reported fall 2025 data, according to the AAU. Admissions and enrollment are not identical but track closely in doctoral education. AAU officials said the takeaway is two straight years of substantial reductions in the number of PhD students admitted and enrolled at major research universities.
“We are at risk of losing a whole generation of new talent because of the reduction in the capacity to support those students,” Toby Smith, a senior vice president at the AAU, told the Times.
2. The universities behind major research are pulling back hardest.
The Massachusetts Institute of Technology in Cambridge expects nearly 20% fewer new graduate students, or a loss of about 500 students, after new federal research awards fell 20%, President Sally Kornbluth, PhD, said in May.
The California Institute of Technology in Pasadena, Calif., is cutting new graduate students 40% for fall 2026 across the board. The University of Washington’s astronomy department in Seattle took no new doctoral students this fall, its first such pause since at least 2016, according to the Times.
3. Uncertainty, not just cuts, is driving the pullback.
The NIH and the National Science Foundation have funded fewer research grants, and the wealthiest universities face a new federal tax on their endowments. But the reason cited most often was the unpredictable nature of federal funding: proposed cuts, congressional reversals and abruptly terminated grants that courts later restored. The whiplash makes multiyear commitments to doctoral students difficult.
“[Developing research talent] is more like planting an orchard than filling a warehouse,” Travis York, PhD, a director at the American Association for the Advancement of Science, told the Times, adding that the effects “will ripple across the U.S. innovation ecosystem for years to come.”
4. International interest is falling fastest.
Applications from domestic students rose 3%, but applications from international students fell 21%, a drop research advocates attribute to delayed visa interviews, an expanded travel ban and social media screening. Mr. Smith said the decline comes as countries such as China ramp up recruitment “to take advantage of the United States’ unforced errors.”
5. Healthcare’s research workforce is already feeling it.
The trend surfaced on clinical operations months ago. PhD programs began shrinking nationwide last fall as federal research funding was frozen, with Harvard University in Cambridge, Mass., reducing PhD slots across dozens of departments, including a 75% cut in a single biology program. Worcester, Mass.-based UMass Chan Medical School rescinded dozens of provisional PhD acceptance offers in March 2025, citing biomedical research funding instability, and Baltimore-based Johns Hopkins University — the largest NIH grant recipient — absorbed the loss of more than $800 million in USAID funding.
The strain extends to those already in the field. In a survey by the New Haven, Conn.-based Yale School of Medicine of 175 early-career physician-scientists, 58% said they were considering leaving academic medicine within two years and 44% were weighing a move abroad, with 82% putting the odds of leaving academia within five years above 50%.
6. The clinical stakes are concrete.
PhD-trained researchers are no longer confined to the lab. Clinically based nurse scientists — nurses who hold a PhD and lead original research — have migrated into hospitals over the past decade, where they design studies on patient satisfaction, cost and quality, mentor bedside staff and bolster Magnet credentials.
On the physician side, academic medical centers have long used split clinical-research roles to keep doctors engaged in inquiry, a model community hospitals have started adopting.
A smaller doctoral pipeline today means fewer clinician-researchers to recruit in five to 10 years. This loss compounds at the hospital bedside. These are people who run the clinical trials that bring new therapies to patients, translate research into practice and lead continuous quality improvement work. Fewer of them means fewer studies started and slower adoption of evidence-based improvements in patient care.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.